Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview

4505studies shown

Showing 1-12 of 4,505

RecruitingNCT07395206

Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

In Berlin

SchizophreniaBehavioural studyAges 18–65

Countries: Germany
Sponsor: Charite University, Berlin, Germany

View study

Not Yet RecruitingNCT07488156

Improving Health Literacy in people with Schizophrenia Spectrum Disorder

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study isn't recruiting yet.

In New Orleans

SchizophreniaBehavioural studyAges 18–65

Countries: United States
Sponsor: Louisiana State University Health Sciences Center in New Orleans

View study

Not Yet RecruitingACTRN12626000605392

Assessing the feasibility of psychological therapy centred on biological and social rhythms to help stabilise mood and reduce Suicide prevention and behaviours in people with schizophrenia or schizoaffective disorder

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study isn't recruiting yet.

In Australia

Schizophrenia, SuicidalityInterventional studyAges 18+

Countries: Australia
Sponsor: Deakin University

View study

Not Yet RecruitingNCT06889025

Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study isn't recruiting yet.

In Kingston

SchizophreniaInterventional studyAges 18+

Countries: Canada
Sponsor: Felicia Iftene

View study

Not Yet RecruitingNCT07184710

This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases Presented With Psychosis in Two Phases to Differentiate Into Two Groups a Case of Schizophrenia or a Case of Methamphetamine Induced Psychosis.

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study isn't recruiting yet.

Location not clearly listed

SchizophreniaObservational studyAges 18–60

Countries
Sponsor: Sohag University

View study

RecruitingNCT06562608

Anticholinergic Deprescription in Schizophrenia

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

In Pittsburgh

SchizophreniaMedication studyAges 40–70

Countries: United States
Sponsor: Deepak K. Sarpal, M.D.

View study

RecruitingACTRN12605000656639

Amisulpride Naturalistic Study

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

Location not clearly listed

SchizophreniaInterventional studyAges 18–65

Countries
Sponsor: Dr. Suresh Sundram

View study

RecruitingNCT06907420

40 Hz Visual Stimulation as an Intervention in Schizophrenia

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

In Munich

SchizophreniaDevice studyAges 18+

Countries: Germany
Sponsor: Technical University of Munich

View study

RecruitingNCT06939088

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Addiction

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

Multiple locations, including Aalborg

Schizophrenia, AddictionMedication studyAges 18–70

Countries: Denmark
Sponsor: Anders Fink-Jensen, MD, DMSci

View study

RecruitingISRCTN83479057

A clinical study to investigate whether third-line treatments work better as a second-line treatment for people diagnosed with schizophrenia

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

In United Kingdom

SchizophreniaResearch studyAges 18–70

Countries: Australia, United Kingdom, Austria, + 4 others
Sponsor: University Medical Center Utrecht

View study

RecruitingACTRN12605000516684

Switching to aripiprazole from other second-generation antipsychotics.

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

Location not clearly listed

SchizophreniaInterventional study

Countries
Sponsor: Bristol Meyers Squibb Pharmaceuticals

View study

RecruitingACTRN12617001547336

The efficacy of Metformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in people with schizophrenia or schizoaffective disorder newly commenced on clozapine

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

Multiple locations, including Herston

SchizophreniaInterventional studyAges 18–64

Countries: Australia
Sponsor: The University of Queensland

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.